Pacira BioSciences (PCRX) Short-term Investments (2011 - 2026)
Pacira BioSciences (PCRX) posted quarterly Short-term Investments of $57.9 million for Q1 2026, down 72.44% year-over-year from $210.0 million in Q1 2025, and down 27.55% quarter-over-quarter from $79.9 million in Q4 2025.
Pacira BioSciences (PCRX) Short-term Investments (2011 - 2026) Analysis & Trends
Pacira BioSciences' Short-term Investments history runs 16 years deep, the most recent figure standing at $57.9 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 72.44% year-over-year to $57.9 million; the TTM figure through Mar 2026 stood at $57.9 million (down 72.44% YoY), while the FY2025 annual figure was $79.9 million, down 61.57% from the prior year.
- Short-term Investments for Q1 2026 stood at $57.9 million, down from $79.9 million in the prior quarter.
- The five-year high for Short-term Investments was $225.4 million in Q1 2022, with the low at $57.9 million in Q1 2026.
- The 5-year median for Short-term Investments is $145.4 million (2025), against an average of $156.7 million.
- The sharpest annual moves came in 2022 and 2026: Short-term Investments jumped 160.5% in 2022, then tumbled 72.44% in 2026.
- Pacira BioSciences' Short-term Investments stood at $184.5 million in 2022, then slumped by 32.1% to $125.3 million in 2023, then surged by 65.9% to $207.8 million in 2024, then slumped by 61.57% to $79.9 million in 2025, then decreased by 27.55% to $57.9 million in 2026.
- Business Quant data shows PCRX's Short-term Investments at $57.9 million in Q1 2026, $79.9 million in Q4 2025, and $98.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Pacira BioSciences | 944.33 Mn | 693.29 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.16 Mn |
| Mar 31, 2026 | 57.87 Mn |
| Dec 31, 2025 | 79.88 Mn |
| Sep 30, 2025 | 98.75 Mn |
| Jun 30, 2025 | 145.38 Mn |
| Mar 31, 2025 | 210.02 Mn |
| Dec 31, 2024 | 207.84 Mn |
| Sep 30, 2024 | 207.85 Mn |
| Jun 30, 2024 | 157.17 Mn |
| Mar 31, 2024 | 141.84 Mn |
| Dec 31, 2023 | 125.28 Mn |
| Sep 30, 2023 | 136.07 Mn |
| Jun 30, 2023 | 133.96 Mn |
| Mar 31, 2023 | 138.45 Mn |
| Dec 31, 2022 | 184.51 Mn |
| Sep 30, 2022 | 219.30 Mn |
| Jun 30, 2022 | 194.33 Mn |
| Mar 31, 2022 | 225.44 Mn |
| Dec 31, 2021 | 70.83 Mn |
| Sep 30, 2021 | 559.82 Mn |